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Objective: Cognitive impairment and depressive symptoms are common among the geriatric population 
but the co-occurrence of both is rarely studied. The purpose of this study was to identify and compare the 
factors associated with three groups of elderly people: those assessed with cognitive impairment alone 
(COG), depressive symptoms alone (DEP) or co-existence of both (COG-DEP).  
Methods: The cross-sectional study included 600 community-dwellers ages 65 and older. All participants 
underwent a comprehensive evaluation. Global cognition was measured by the Mini-Mental State 
Examination (MMSE) and depressive symptoms were deﬁned by the Geriatric Depression Scale (GDS). 
Speciﬁc chronic illnesses relevant to the Charlson comorbidity index (CCI) were self-reported. Functional 
status was evaluated by the Katz’ basic (ADL) and Lawton’s instrumental (IADL) activities of daily living 
scales.  
Results: COG-DEP was explained by IADL dependence (OR: 11.9, 95% CI: 4.59–30.78), ADL 
dependence (OR: 11.5, 95% CI: 5.59–23.69), cerebrovascular disease (OR: 3.6, 95% CI: 1.48–8.68), 
congestive heart failure (OR: 3.4, 95% CI: 1.77–6.59) and diabetes (OR: 2.6, 95% CI: 1.30–5.18), but it 
was best predicted by functional limitations in the adjusted model. Being functionally dependent and 
medically ill with shorter life expectancy was shown to signiﬁcantly increase the odds of being DEP. 
Functional limitation in IADL was without distinction associated to COG, DEP and COG-DEP.  
Conclusion: The present results on COG, DEP and COG-DEP show the particular relevance of certain 
medical comorbidities and functional limitations to those three distinct groups of elderly people. 
Key words: cognitive impairment; geriatric depression; medical comorbidity; functional limitation; life expectancy; elderly 
people  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction  
As long as mortality in old age continues to fall and 
fertility remains low, the proportion of older persons 
will continue to increase. The percentage of the 
Spanish population aged 60 years and older 
represents 22.2% of the whole population (United 
Nations, 2009). Due to senescence, elderly people are 
at a particularly high risk of developing illnesses 
related to aging, not to mention cognitive impairment, 
which has been shown to affect 22.2% of the elderly 
population (Millán-Calenti et al., 2009).  
Research has shown that cognitive decline, 
reaching the threshold for dementia, affects a large 
proportion of elderly in-patients and is associated 
with certain alterations (Holstein et al., 1994), the 
treatment of which is complicated by the mental state 
of this segment of the population, as missed diagnosis 
and self-neglect are likely (Wolf-Klein et al., 1988; 
Löppönen et al., 2004). According to the most recent 
studies, the number of comorbid conditions seems to 
be similar in demented and non-demented subjects, 
but certain chronic medical conditions have been 
shown to be differentially associated with the 
cognitively impaired as compared to the unimpaired 
(Zekry et al., 2008). For example, heart disease, 
stroke and diabetes have been reported to be 
associated with cognitive impairment (Breteler et al., 
1994; Ferrucci et al., 1996; Strachan et al., 1997). Not 
only the presence of medical conditions but also 
declines in the ability to perform certain activities 
considered important in independent functioning (e.g. 
activities of daily living (ADL) and instrumental 
activities of daily living (IADL)) were shown to be 
associated with cognitive impairment (Bassett and 
Folstein, 1991; Artero et al., 2001).  
It has been observed that a large proportion of 
cognitively impaired geriatric out-patients have been 
diagnosed with depression. However, the rate of 
coexisting depression decreased signiﬁcantly with 
increasing severity of cognitive impairment: 33% of 
mildly impaired patients were depressed, compared 
with 23% of moderately impaired and 12% of 
severely impaired (Reiﬂer et al., 1982). Depressive 
symptoms (referring to mood and affective 
syndromes rather than clinical depression, which 
fulﬁls rigorous diagnostic criteria) were shown to be 
more frequent among the non-clinical population of 
elderly people (Zung, 1967) and to similarly co-exist 
with cognitive impairment. It has been shown that 
some diseases that alter biological systems can play a 
role in the development of speciﬁc psychological 
disturbances. Depressive symptoms are highly 
prevalent in patients with congestive heart failure 
(Charlson and Peterson, 2002), but the link between 
cognitive impairment coexisting with depression and 
chronic illnesses is unclear. The same can be reported 
for other important limitations, like the ability to 
perform ADL and IADL (Armenian et al., 1998).  
Cognitively impaired and/or depressed elderly 
people are likely to experience different medical 
conditions and functional limitations, and thus may 
have different health care needs. In this study 
examining a large sample of community-dwelling 
older adults, we sought to identify and compare the 
factors associated with three groups of elderly people: 
those assessed with cognitive impairment alone 
(COG), depressive symptoms alone (DEP) and co-
existence of both (COG-DEP). That is to say, we 
wanted to primarily determine whether certain 
medical comorbidities and functional limitations were 
similarly associated to COG, DEP and COG-DEP and 
then examine the independent effect of those 
variables on COG, DEP and COG-DEP by use of a 
multivariate model.  
Methods  
Selection and description of participants  
Data for this study came from a representative sample 
(N ¼ 600) of community-dwelling residents of Narón 
Council (A Coruña, Spain), aged 65 years and older. 
The subjects were selected from the municipal 
register using a random number table, arranged by 
age quinquennia and sex. In the sample, mean ± 
standard deviation (SD) age was 75.1 ± 7.5 years 
(75.9 ± 8.0 years for women and 73.9 ± 6.7 years for 
men). The level of conﬁdence was 95%, sampling 
error ± 4% and estimation for data losses 10%.  
Procedure  
The study protocol was approved by the Ethics 
Committee at the University of A Coruña. 
Participants were individually assessed in a health 
centre, or at home in the case of people with mobility 
difﬁculties. Before the data collection, all participants 
were informed about the study and signed the 
corresponding informed consent form.  
Variables and instruments  
Cognitive status was assessed by a psychologist using 
the Mini-Mental State Examination (MMSE) 
(Folstein et al., 1975). This questionnaire includes 
items assessing ﬁve cognitive domains, with a 
maximum score of 30 corresponding to the best 
cognitive status and a cut-off score of 23 or less 
indicating cognitive impairment (COG). However, it 
is widely accepted that this cut-off score must be 
varied according to age and educational level, 
particularly when assessing elderly populations 
(Morgado et al., 2010). Crum et al. (1993) examined 
the distribution of the MMSE score according to age 
and educational level and deﬁned cutoff median 
scores according to those criteria. In this paper, 
cognitive impairment is deﬁned according to Crum’s 
cut-off median scores. The score was treated as a 
continuous variable in multivariate analysis. The 
acceptance rate to undergo the MMSE test was 
98.5%. Nine subjects with minimal level of 
consciousness were excluded from the random 
sample as they were unable to be assessed by the 
MMSE.  
Depressive symptoms were also assessed by a 
psychologist, using the short-form of the Geriatric 
Depression Scale (GDS-SF) (Sheikh and Yesavage, 
1986). This questionnaire was scored to yield a 
continuous scale from 0 to 15, with a score of 6 or 
higher indicating probable clinical depression (DEP) 
(Herrmann et al., 1996). Due to data losses, 12 
additional individuals were excluded from the study.  
The standardized Older Americans Resources and 
Services (OARS) questionnaire (Duke University, 
1978) was used to assess socio-demographic and 
general health status variables. Medical histories were 
collected by a physician or a trained nurse in charge 
of the participant during the research. Participants´ 
report was given by the patient or their relatives 
according to medical records. Comorbidity conditions 
were deﬁned according to the Charlson comorbidity 
index (CCI) (Charlson et al., 1987). The weighted 
index taking into account both the number and the 
seriousness of comorbid diseases served to calculate a 
comorbidity score. A composite comorbidity-age 
score was created by adding to the comorbidity score 
an age points coded in decades. The composite 
comorbidity-age score was then used to calculate a 
10-year survival expectancy estimation for each 
participant in a low-risk population.  
Functional status was measured using the ADL 
(Katz et al., 1963) and IADL (Lawton and Brody, 
1969) scores. Participants were asked by a physician 
or a trained nurse if they had any difﬁculty 
performing each task without the help of another 
person. Individuals who were unable to perform any 
one of the activities were considered to be 
functionally incapacitated in that activity (ADL or 
IADL dependent). With regard to the remaining 
pathologies suffered (personal background and 
illnesses), data were obtained from the participants’ 
report, collecting the answers given by the patient or 
their relatives according to the medical records.  
Statistical analysis  
Analyses assessed the prevalence of cognitive impair-
ment and depressive symptomatology, and the related 
sociodemographic, comorbidity illnesses and func-
tional status variables. Spearman’s correlation coefﬁ-
cient (r) was used to analyse the association between 
quantitative variables. The crude odds ratio (OR) 
measured the association for dichotomous variables 
of nominal level or higher. Categorical differences 
were tested with Chi-square (x 
2
) analysis, and 
continuous variables were compared using the 
Kruskal–Wallis test. To adjust for the confounding 
effect of variables correlated with each other, 
multinomial logistic regression assessing cognitive 
functioning, depressive symptoms and both was then 
used. The model estimated the independent effect of 
each correlate, and the odds ratios (OR) along with 
their 95% conﬁdence intervals (CI) were calculated.  
Statistical signiﬁcance was set at p < 0.05. Statistical 
analyses were performed using the SPSS statistical 
package version 16.0.1 (SPSS Inc., 2007).  
Results  
Co-occurrence of cognitive impairment 
and depressive symptoms  
In the sample used for this study the mean ±standard 
deviation (SD) for cognitive performance, according 
to the MMSE scale, was 23.9 ±5.6, and that for the 
number of depressive symptoms, as measured by the 
GDS-SF scale, was 3.9 ±3.3. We found that cognitive 
performance was negatively correlated to the amount 
of depressive symptoms (Spearman correlation r 
¼-0.3, p < 0.001). As shown in Table 1, 12.6% of the 
participants were found to have cognitive impairment 
alone (COG), without depressive symptoms, and 
17.3% were assessed with depressive 
symptomatology alone (DEP), without cognitive 
impairment. Considering full independence of the 
variables, we would have expected 5.2% of the 
sample to report both (COG-DEP), but in fact nearly 
7.9% did (OR ¼ 2.3 (1.48–3.49)). 
Table 2 presents the characteristics of the sample as 
a function of cognitive status and/or depressive 
symptoms of the participants. The oldest subjects 
(285 years) were more COG (29.4%) and presented 
more COG-DEP (22.1%) than the rest of the 
population. Those cognitive and psychological afﬂic-
tions, predominantly DEP, affected women primarily 
(22.7%) and particularly those with no formal 
education (19.3%). Those solely DEP and those 
COG-DEP were also more medicated, with 26.5% of  
the participants consuming more than six drugs when 
DEP and 15.7% when COG-DEP (x 
2 
¼ 38.4, 9 df, p 
< 0.001). 
Medical comorbidity, functional limitation and risk 
of cognitive and/or depressive disorders  
In Table 2, solely COG and solely DEP participants 
were shown to suffer similar average amount of 
diseases (5.8 and 5.6, respectively), as assessed in the 
composite Charlson comorbidity-age score. COGDEP 
participants reported a higher average amount of 
disease according to age, 6.5. Solely COG and solely 
DEP participants were shown to have comparable 
mean predicted 10-year survival expectancies (2.3 
and 2.0 years, respectively), which was greater than 
the mean for COG-DEP participants: 1.6 years. 
Participants without cognitive impairment and 
depressive symptoms were on average healthier and 
had a higher life expectancy. Notably, as disparity in 
the sample is very important, the accuracy of those 
values should be viewed cautiously. 
 
Table 1 Co-occurrence of cognitive impairment and depressive symptomatology  
GDS-SF 
 No depressive symptoms Depressive symptoms Total 
 N (%) N (%) 
N (%) 
MMSE    
No cognitive impairment 360 (62.2) 100 (17.3) 460 (79.5) 
Cognitive impairment 73 (12.6) 46 (7.9) 119 (20.5) 
Total 433 (74.8) 146 (25.2) 579 (100.0) 
    
MMSE, Mini-Mental State Examination; GDS-SF, Short-form of the Geriatric Depression Scale. 
Prevalence odds ratio ¼2.3 (1.48–3.49).  
As shown in Table 3, elderly people with cancer were 
3.7 times more likely to be solely COG than be 
without cognitive impairment and depressive 
symptoms (with cancer referring to any malignancy, 
including those that spread to the brain). Subjects 
solely DEP differed in terms of limitations and 
diseases, with the most common ailments concerning: 
visual limitation (OR 2.5, 95% CI 1.24–4.91), 
connective tissue (OR 3.6, 95% CI 1.78–7.11), 
peripheral vascular (OR 1.9, 95% CI 1.20–2.97) and 
ulcer (OR 1.9, 95% CI 1.20–3.06) diseases. 
Additionally, people limited visually (OR 3.9, 95% CI 
1.72–8.78) and auditorily (OR 2.8, 95% CI 1.38–5.57) 
and those suffering, from dementia (OR 16.3, 95% CI 
1.45–186.66), cerebrovascular disease (OR 3.6, 95% 
CI 1.48–8.68), congestive heart failure (OR 3.4, 95% 
CI 1.77–6.59) and diabetes (OR 2.6, 95% CI 
1.30–5.18), were found to be signiﬁcantly more likely 
to be COG-DEP.  
Concerning functional disability, participants assessed 
with cognitive and/or depressive disorders in Table 3 
were all dependent in instrumental (IADL) and basic 
(ADL) activities of daily living. Elderly people 
dependent in IADL were 4.4 times more likely to be 
solely COG, 2.2 times more likely to be solely DEP 
and 11.9 times more likely to be COG-DEP. 
Participants dependent in ADL were almost four times 
more likely to be COG-DEP rather than solely COG or 
DEP, which was signiﬁcant at the p ¼ 0.001 level.  
Multivariate analysis  
Many of the variables examined in Table 3 may be 
correlated with each other. Thus, the multinomial 
logistic regression analysis presented in Table 4 was 
used to control for confounding effects. After ﬁtting 
the multinomial logistic regression, the apparent 
association based on crude odds ratio for sex and 
cognitive and/or depressive disorders remained sig-
niﬁcant at p < 0.05. Age was no longer associated to 
COG-DEP, and it was marginally signiﬁcant for solely 
COG and solely DEP. In this study, educational 
attainment was not associated to cognitive and/or 
psychological functioning when cognitive impairment 
was deﬁned by a cut-off score based on age-and 
education-speciﬁc norms.  
 
 
 
 
 
 
 
 
 
 
 
Table 2 Characteristics of elderly patients with cognitive impairment alone (COG), depressive symptoms alone (DEP) and co-existence (COG-DEP) or not 
(NCOG-NDEP) of cognitive impairment and depressive symptoms  
 
 
Categorical variables: data expressed as number of cases (%) ( p-value of Chi-square test comparing four groups). Continuous variables: data expressed as mean ± 
SD ( p-value of Kruskal–Wallis test comparing four groups). *p < 0.05. **p < 0.001.  
 
 
 
For the solely COG, limitations in instrumental 
functional autonomy remained signiﬁcant in Table 4 
at the p < 0.001 level when all possible confounders 
were controlled for simultaneously, whereas 
limitations in basic functional autonomy was no 
longer associated. All the correlates that were 
associated with DEP alone in the unadjusted analyses 
remained signiﬁcant in the full-adjusted model. There 
was a signiﬁcant decrease in 10year survival 
expectancy (OR 0.3, 95% CI 0.09–0.65) for those 
DEP. Being a woman (OR 3.2, 95% CI 1.87–5.43), 
having limitations in IADL (OR 2.5, 95% CI 
1.46–4.31) and ADL (OR 1.9, 95% CI 1.14–3.16) 
increased the risk ofDEP alone. For elderlypeople, the 
independent effects of limitations in instrumental and 
basic functional autonomy persisted in their relation 
to COG-DEP after adjusting for the other correlates. 
Elderly women (OR 4.3,95% CI1.89–9.96) with 
limitations in IADL(OR 6.7, 95% CI 2.30–19.56) and 
ADL (OR 4.6, 95% CI 2.07– 10.20) were more likely 
to experience COG-DEP.  
 NCOG-NDEP COG  DEP  COG-DEP  
 n = 360 n = 73  n = 100  n = 46  
 N (%) N (%)  N (%)  N (%)  x 2  df  
Age       
65–74  227 (70.5)  24 (7.5)  61 (18.9)  10 (3.1)  65.3**  6  
75–84  108 (57.2)  29 (15.3)  31 (16.4)  21 (11.1)    
285  25 (36.7)  20 (29.4)  8 (11.8)  15 (22.1)    
Sex        
Men  194 (76.6)  24 (9.5)  26 (10.3)  9 (3.6)  42.3**  3  
Women  166 (51.0)  49 (15.0)  74 (22.7)  37 (11.3)    
Educational level        
No formal education  289 (59.4)  63 (12.9)  94 (19.3)  41 (8.4)  14.2*  6  
Primary  55 (79.7)  7 (10.2)  5 (7.2)  2 (2.9)    
>=Secondary  14 (77.8)  2 (11.0)  1 (5.6)  1 (5.6)    
IADL dependence        
Absent  213 (77.2)  18 (6.5)  40 (14.5)  5 (1.8)  61.9**  3  
Present  147 (48.5)  55 (18.2)  60 (19.8)  41 (13.5)    
ADL dependence        
Absent  282 (72.1)  42 (10.8)  56 (14.3)  11 (2.8)  68.5**  3  
Present  78 (41.5)  31 (16.5)  44 (23.4)  35 (18.6)    
Visual limitations        
No  336 (64.1)  67 (12.8)  85 (16.2)  36 (6.9)  15.0*  3  
Yes  24 (43.6)  6 (10.9)  15 (27.3)  10 (18.2)    
Hearing limitations        
No  311 (64.1)  58 (12.0)  84 (17.3)  32 (6.6)  9.6*  3  
Yes  49 (52.1)  15 (16.0)  16 (17.0)  14 (14.9)    
Number of medication        
0–1  111 (75.0)  20 (13.5)  14 (9.5)  3 (2.0)  38.4**  9  
2–3  112 (64.3)  25 (14.4)  24 (13.8)  13 (7.5)    
4–5  90 (58.1)  16 (10.3)  35 (22.6)  14 (9.0)    
26  47 (46.1)  12 (11.7)  27 (26.5)  16 (15.7)    
 Mean ± SD  Mean ± SD  Mean ± SD  Mean ± SD  x 2  df  
Composite comorbidity-age score  5.0 ± 1.6  5.8 ± 2.0  5.6 ± 1.6  6.5 ± 2.2  30.8**  3  
Predicted 10-year survival 
expectancy (years) 
3.2 ± 3.0  2.3 ± 2.9  2.0 ± 2.6  1.6 ± 2.6  30.8**  3  
       
       
Absent  213 (77.2)  18 (6.5)  40 (14.5)  5 (1.8)  61.9**  3  
Present  147 (48 5) 55 (18.2)  60 (19.8)  41 (13.5)    
ADL dependence        
Absent  282 (72.1)  42 (10.8)  56 (14.3)  11 (2.8)  68.5**  3  
Present  78 (41.5)  31 (16.5)  44 (23.4)  35 (18.6)    
Visual limitations       
No  336 (64.1)  67 (12.8)  85 (16.2)  36 (6.9)  15.0*  3  
Yes  24 (43.6)  6 (10.9)  15 (27.3)  10 (18.2)    
Hearing limitations        
No  311 (64.1)  58 (12.0)  84 (17.3)  32 (6.6)  9.6*  3  
Yes  49 (52.1)  15 (16.0)  16 (17.0)  14 (14.9)    
Number of medication        
0–1  111 (75.0)  20 (13.5)  14 (9.5)  3 (2.0)  38.4**  9  
2–3  112 (64.3)  25 (14.4)  24 (13.8)  13 (7.5)    
4–5  90 (58.1)  16 (10.3)  35 (22.6)  14 (9.0)    
26  47 (46.1)  12 (11.7)  27 (26.5)  16 (15.7)    
 Mean ± SD  Mean ± SD  Mean ± SD  Mean ± SD  x 2  df  
Composite comorbidity-age score  5.0 ± 1.6  5.8 ± 2.0  5.6 ± 1.6  6.5 ± 2.2  30.8**  3  
Predicted 10-year survival  3.2 ± 3.0  2.3 ± 2.9  2.0 ± 2.6  1.6 ± 2.6  30.8**  3  
expectancy (years)        
 
Table 3 Cognitive impairment (COG), depressive symptoms (DEP) and both coexisting (COG-DEP), and risk estimates of sociodemographics, functional status 
and medical comorbidities  
 COG (n=73) DEP (n = 100) COG-DEP (n = 46) 
 ORa (95% CI) ORa (95% CI) ORa (95% CI) 
Age    
285 (vs. 65–74)  7.6 (3.67-15.59)** 1.2 (0.51-2.77) 13.6 (5.54-33.52)** 
75–84 (vs. 65–74)  2.5 (1.41-4.57)* 1.1 (0.66-1.74) 4.4 (2.01-9.70)** 
Sex (Female vs. male)  2.4 (1.40-4.06)* 3.3 (2.03-5.44)** 4.8 (2.25-10.25)** 
Educational level    
>=Secondary (vs. no formal 
education)  
0.7 (0.15-2.96) 0.2 (0.03-1.69) 0.5 (0.06-3.93) 
Primary (vs. no formal 
education)  
0.6 (0.25-1.34) 0.3 (0.11-0.72)* 0.3 (0.06-1.09) 
IADL dependence  4.4 (2.50-7.85)** 2.2 (1.38-3.42)* 11.9 (4.59-30.78)** 
ADL dependence  2.8 (1.78-4.54)** 2.7 (1.58-4.52)** 11.5 (5.59-23.69)** 
Visual limitations  1.3 (0.49-3.19) 2.5 (1.24-4.91)* 3.9 (1.72-8.78)* 
Hearing limitations  1.6 (0.86-3.12) 1.2 (0.65-2.23) 2.8 (1.38-5.57)* 
Number of medication    
>=6(vs. 0–1)  1.4 (0.64-3.13) 4.6 (2.20-9.45)** 12.6 (3.50-45.28)** 
4–5 (vs. 0–1)  1.0 (0.48-2.01) 3.1 (1.56-6.08)* 5.8 (1.60-20.65)** 
2–3 (vs. 0–1)  1.2 (0.65-2.36) 1.7 (0.84-3.45) 4.3 (1.19-15.49)** 
Diseases assessed in the CCI    
Myocardial infarction  0.6 (0.28-1.48) 0.9 (0.47-1.74) 1.3 (0.56-2.89) 
Congestive heart failure  1.2 (0.59-2.24) 0.9 (0.46-1.63) 3.4 (1.77-6.59)** 
Peripheral vascular disease  1.7 (1.00-2.76) 1.9 (1.20-2.97)* 1.2 (0.63-2.14) 
Cerebrovascular disease  2.1 (0.88-4.95) 1.9 (0.85-4.18) 3.6 (1.48-8.68)* 
Dementia  26.4 (3.04-229.49)** 7.3 (0.66-81.64) 16.3 (1.45-183.66)* 
Chronic pulmonary disease  1.0 (0.49-1.99) 1.1 (0.63-2.06) 1.3 (0.62-2.95) 
Connective tissue disease  0.7 (0.42-1.22) 3.6 (1.78-7.11)** 1.9 (0.85-4.16) 
Ulcer disease  0.6 (0.30-1.15) 1.9 (1.20-3.06)* 0.9 (0.46-1.93) 
Liver disease mild  2.1 (0.85-5.36) 0.6 (0.18-2.17) 0.5 (0.06-3.45) 
Diabetes  1.2 (0.59-2.31) 1.1 (0.66-2.08) 2.6 (1.30-5.18)* 
Cancer  3.7 (1.14-12.03)* 0.5 (0.06-4.19) 1.1 (0.14-9.32) 
    
 
 
IADL, Instrumental Activities of Daily Living; ADL, Basic Activities of Daily Living. 
CCI, Charlson Comorbidity Index. 
aOR ¼ crude odds ratio (CI ¼ conﬁdence interval). 
*Signiﬁcant correlations are indicated in bold p < 0.05. 
**p < 0.001. 
 
 
 
Discussion  
The rate for depressive symptoms among older adults is 
consistent but slightly higher than the average 
prevalence of depressed older adults in a worldwide 
community-based study, yielding 13.5% (Beekman et 
al., 1999). An explanation for the difference observed 
may be that the study did not use the same instruments 
for depressive assessments. In our case, depression was 
measured using a self-report rating scale and the results 
pertained to clinically relevant syndromes rather than 
depressive disorders as deﬁned in the DSM-IV-TR 
classiﬁcation (American Psychiatric Association, 2001). 
However, depressive syndromes not fulﬁlling rigorous 
diagnostic criteria are highly prevalent in older adults, 
while their consequences have been shown to be similar 
to those of major depressive illness (Wells et al., 1989; 
Beekman et al., 1997).  
Depression is a common feature of cognitive 
impairment in older age (Forsell et al., 2003; 
Gabryelewicz et al., 2004). Our ﬁndings are consistent 
with these studies, suggesting that cognitive impairment 
and depressive symptoms coexist for 7.9% of the 
sample. Whether depressive symptoms are a reaction to 
cognitive deﬁcits or constitute an early symptom of 
neurodegeneration is unclear. Some studies have 
suggested that depressive symptoms follow the onset of 
dementia (Chen et al., 1999; Vinkers et al., 2004). 
Conversely, research on the glucocorticoid cascade in 
the hippocampus have shown that older depressed adults 
with high or rising cortisol levels during 5 years have 
poorer memory and greater hippocampal atrophy 
(Lupien et al., 1998). These ﬁndings have been 
supported by studies that show that cognitive function 
can improve when depressive symptoms are treated 
(Bulbena and Berrios, 1993), although some degree of 
cognitive impairment may remain even after recovery 
(Marcos et al., 1994; Kessing, 1998). An alternative 
explanation was that the symptoms of cognitive 
deterioration may partially overlap with the symptoms of 
depression, and the underlying neuropathological 
condition that causes cognitive impairment also causes 
depressive symptoms (Barnes et al., 2006; Panza et al., 
2010). Due to the high prevalence of depression in 
cognitive decline and their common adverse con-
sequences such as apathy, agitation and social with-
drawal, screening for depression and cognitive 
impairment remains an important challenge for 
psychogeriatric medicine (Lyketsos et al., 2000).  
Solely COG, solely DEP or both simultaneously 
(COG-DEP) have been associated to certain socio-
demographic characteristics. In contrast to other authors 
(Luck et al., 2010; Morgado et al., 2010) we did not ﬁnd 
a clear relationship of cognitive function with age and 
low educational attainment, most likely because in our 
study cognitive impairment was based on both variables 
so that discrepancies on age and education were 
minimized (Crum et al., 1993). Meanwhile, being a 
woman has been reported to be independent correlate of 
COG, DEP or COG-DEP and many authors agree on the 
fact that women in the general population suffer from 
more depressive symptoms than men (Kockler and 
Heun, 2002). It has been suggested that risk factors were 
rather associated to biological sex, as the impact of 
gender on psychological health was demonstrated not to 
vary across societies whether they were promoting an 
egalitarian culture between men and women or not 
(Zunzunegui et al., 2007). As cognitive impairment and 
depression are closely related, differences in sex were 
also observed for the COG and the COG-DEP elderly 
people, although it could be argued that COG and 
COG-DEP may be better explained by the worse 
physical state observed in older women (Agüero-Torres 
et al., 2002; Millán-Calenti et al., 2010).  
 
 
Table 4 Multinomial logistic regression model predicting the effect of functional limitation and survival expectancy, as a function of medical comorbidities, on 
cognitive impairment (COG), depressive symptoms (DEP), and both coexisting (COG-DEP), adjusting for sociodemographics  
 COG (n=73) DEP (n = 100) COG-DEP (n = 46) 
 ORa (95% CI) ORa (95% CI) ORa (95% CI) 
    
Age  1.1 (1.03-1.13)* 0.9 (0.89-0.98)* 1.0 (0.99-1.11) 
Sex (Female vs. male)  2.7 (1.49-4.84)* 3.2 (1.87-5.43)** 4.3 (1.89-9.96)* 
Education     
>= Secondary (vs. no formal education)  1.3 (0.26-6.67) 0.5 (0.06-4.20) 2.1 (0.18-22.95) 
Primary (vs. no formal education)  1.1 (0.45-2.75) 0.5 (0.17-1.23) 0.8 (0.16-3.75) 
IADL dependence  3.4 (1.72-6.54)** 2.5 (1.46-4.31)* 6.7 (2.30-19.56)* 
ADL dependence  1.2 (0.65-2.22) 1.9 (1.14-3.16)* 4.6 (2.07-10.20)** 
10-year survival expectancy  2.7 (0.83-8.48) 0.3 (0.09-0.69)* 1.6 (0.33-7.78) 
    
 
 
IADL, Instrumental Activities of Daily Living; ADL, Basic Activities of Daily Living. Model reference category ¼ no cognitive impairment and no depressive 
symptoms (NCOG-NDEP); model Chi-square test: 215.7; df 21; p < 0.001. 
a
OR ¼ adjusted odds ratio (CI ¼ conﬁdence interval). *Signiﬁcant correlations are 
indicated in bold p < 0.05. **p < 0.001.  
Previous studies on community-based samples 
have not reported on the correlates of co-occurrence 
of cognitive impairment and depressive symptoms. 
To address the problem, comorbidity illnesses were 
assessed for their differential association with COG, 
DEP and COG-DEP. Our study clearly demonstrated 
that certain comorbidities reported in the CCI were 
speciﬁc to COG, DEP and COG-DEP. Nonetheless it 
must be considered before interpreting these ﬁndings 
that this cross-sectional study is not appropriate for 
drawing causal interferences. While it is likely that 
physical and psychological changes related to chronic 
medical conditions can cause cognitive impairment 
and/or depressive symptoms, COG and/or DEP may 
also worsen chronic medical conditions due to poor 
self-care. Despite the strength of this study, including 
large number of subjects, valid measurement instru-
ments and adjustment for multiple potential con-
founders, some limitations should nevertheless be 
pointed out. It cannot be excluded that the measure-
ment of depressive symptoms could be confounded 
with the measurement of disability, with depressed 
elderly giving unrealistically pessimistic appraisals of 
their disabilities (Kempen et al., 1996). Additionally, 
chronic medical conditions were established using 
patients’ reports, but Kriegsman et al. (1996) demon-
strated that deviations in cognitive function and 
depressive symptomatology had no inﬂuence on the 
level of accuracy.  
Primarily, our results showed that cancer was more 
prevalent in participants COG. This could be an 
indirect effect of health and psychological factors 
increasing vulnerability to cognitive dysfunction, as it 
is the case after chemotherapy for breast cancer 
(Vearncombe et al., 2009). Cognitive dysfunction is 
also a common occurrence among patients with small-
cell lung cancer, although prophylactic cranial 
irradiation has been described as one explanation for 
these cognitive deﬁcits (Meyers et al., 1995). Poor 
cognitive performance was also highly prevalent in 
patients with heart disease, stroke and diabetes 
(Breteler et al., 1994; Ferrucci et al., 1996; Strachan 
et al., 1997) and was not reported in our study of 
solely COG participants. Secondarily, some evidence 
suggests an association between DEP and connective 
tissue disease, visual limitation, ulcers and peripheral 
vascular disease. Studies show that patients with 
arthritis, visual limitation or gastrointestinal diseases 
often score highly on measures of depression (Jess 
and Eldrup, 1994; Ormel et al., 1997; Papadopoulos 
et al., 2005). The limited available data suggest that 
depression may precede the development of ulcers. 
Participants with peripheral vascular diseases seemed 
to experience more depressive symptoms than 
reported by other researchers, who rather stressed the 
importance of heart conditions and diabetes (Ormel et 
al., 1997; Charlson and Peterson, 2002). Thirdly, 
chronic medical conditions varied in the extent they 
were associated with COG-DEP. In this study, 
COG-DEP was experienced by patients with vision 
impairment, cerebrovascular disease, congestive heart 
failure, hearing impairment and diabetes. As 
previously described (Reuben et al., 1999), sensory 
impairment in the elderly was independently 
associated with IADL restriction in household 
maintenance activities, but not with cognitive 
performances. The chronic medical conditions cited 
above are commonly associated with depression alone 
or cognitive impairment alone rather than 
co-occurrence of both. The present results on COG, 
DEP and COG-DEP show the particular relevance of 
certain CCI conditions to those three distinct groups.  
Elderly people with COG and/or DEP were shown 
to have signiﬁcantly larger numbers of comorbidity 
conditions and to be polymedicated (6 drugs or 
more). This was more evident for DEP people for 
whom poorer outcomes remained signiﬁcantly associ-
ated even after adjustment for socio-demographics 
and functional status. In the study by Penninx et al. 
(1999), depressive symptoms and comorbidity also 
predicted higher long-term mortality when controlling 
for comorbidity and physical function. Ultimately, 
patients with increased comorbidity were also shown 
to be at higher risk for functional deterioration in 
basic and instrumental activities of daily living, 
impairing their quality of life. Signiﬁcant new 
research is needed to determine whether among 
patients with the greatest comorbidity and functional 
limitations, by preventing or treating new cognitive 
decline and/or depressive symptoms, morbidity and 
mortality also can be reduced. Additionally, if chronic 
medical conditions are interpreted as a risk for COG 
and/or DEP, they might help understanding the 
pathophysiology of depression and cognitively 
impairment. Inversely, if comorbidities are regarded 
as a consequence of cognitive impairment and/ or 
depressive symptoms, their presence could help the 
clinician in solidifying the diagnosis of COG and 
DEP.  
Conclusions  
Our ﬁndings suggest that elderly people with COG, 
DEP and COG-DEP should be carefully screened for 
associated chronic medical conditions, and vice versa. 
However, controlled trials are necessary to assess the 
impact this may have on service utilization. 
Additionally, if comorbidity is not adequately 
measured in COG and/ or DEP elderly people, there is 
an important potential for confounding. Studies must 
be designed with appropriate methodology to measure 
the independent impact of comorbidity disease on 
outcomes. Another potential direction for research is 
exploring medical illness in subtypes of depression 
and cognitive impairment.  
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Key Points  
• The co-occurrence of cognitive impairment 
and depressive symptoms (COG-DEP) was explained 
by IADL and ADL dependence, cerebrovascular 
disease, congestive heart failure and diabetes, but it 
was best predicted by functional limitations in the 
adjusted model.  
• Being functionally dependent and medically 
ill with shorter life expectancy was shown to 
signiﬁcantly increase the odds of being DEP.  
• Functional limitation in IADL was without 
distinction associated to COG, DEP or both 
(COG-DEP). 
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